Takeda

Contact
takeda.it
+39-06-50260-1

Takeda Italia S.p.A.

Via Elio Vittorini 129
00144 Roma
Italy
+39-06-50260-1
takeda.it
Contact
Profile News
Contact

About Takeda

Takeda Italia is the subsidiary which, with its almost 500 employees, net sales for about 400 million euro and an innovative production plant, provides Takeda’s drugs and services to Italian medical professionals and patients. Ethical drugs are Takeda's core business. Takeda Italia's portfolio includes drugs for the treatment of: peptic ulcers, prostate cancer and endometriosis, urological diseases, diabetes and hypertension, respiratory and inflammatory diseases, osteoporosis, pain management.

Read more about Takeda
Facts about Takeda
  • Focus : Manufacturer
  • Industry : Pharma

News about Takeda

Takeda

01-Dec-2016 | business & finance

Takeda to invest more than 100 million Euros in dengue vaccine manufacturing plant

Takeda Pharmaceutical Company Limited announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine ...

Read news
Takeda

15-Oct-2015 | science

UCL and Takeda announce a new research partnership

Aims the identification of novel therapeutic targets for neurodegenerative diseases

Read news
Takeda

24-Jan-2011 | research and development

Evotec to Collaborate with Takeda Cambridge for Multi-target Hit Identification

Evotec AG  announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and ...

Read news
Takeda

24-Aug-2010 | research and development

Approval of Additional Indication of NESINA: Combination Therapy with Thiazolidinediones for Type 2 Diabetes in Japan

Takeda Pharmaceutical Company Limited announced that an additional indication for “NESINA®” (generic name: Alogliptin), combination therapy with ...

Read news
Takeda

31-Aug-2009 | research and development

Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin for Treatment of Type 2 Diabetes

Takeda Pharmaceutical Company Limited and Takeda Global Research & Development Center, Inc., a wholly owned United States subsidiary, jointly announced ...

Read news
Takeda

25-Aug-2009 | business & finance

Takeda Reacquires Rights to Diabetes Drug in Canada

Takeda Canada, Inc. announced that it has reacquired the Canadian commercial rights to ACTOS(R) (pioglitazone HCl), an oral treatment for type 2 diabetes, ...

Read news
Takeda

23-Apr-2008 | business & finance

Kinaxo Biotechnologies Enters Agreement with Takeda

Kinaxo Biotechnologies announced that it has entered an agreement with Takeda San Diego, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company ...

Read news
Show more news about Takeda

Here you will find Takeda Italia S.p.A.